OCX: Oncocyte Corporation Common Stock Company Profile & Statistics

About

OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.

Info & Links

CEO

Joshua Riggs

Headquarters

15 CUSHING
IRVINE, CA 92618, UNITED STATES

Auditor

Marcum LLP

Share holders

182

Employees

Oncocyte Corporation Common Stock Statistics

Valuation Measures

Market Capitalization²

77.50M

Enterprise Value

48.55M

Enterprise Value/EBITDA(ttm)

-0.85

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

66.96

Price to Book(mrq)

4.72

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

48.39%

Operating Margin(ttm)

-6122.29%

Profit Margin(ttm)

-4664.95%

Return on Equity(ttm)

-269.32%

Return on Invested Capital(ttm)

125.15%

Return on Assets(ttm)

-59.71%

Income Statement

Revenue(ttm)

3.84M

Revenue Per Share(ttm)

0.13

Gross Profit(ttm)

2.02M

EBITDA(ttm)³

-56.85M

Net Income Available to Common(ttm)

-58.26M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

0.90

52-Week Change

-3.99%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

28.60M

Dividend Yield

0.00%

Float⁴

17.18M

% Held by Insiders

1.58%

% Held by Institutions

55.35%

Balance Sheet

Total Cash(mrq)

31.03M

Total Cash Per Share(mrq)

1.08

Total Debt(mrq)

2.07M

Total Debt/Equity(mrq)

20.30%

Current Ratio(mrq)

3.75%

Quick Ratio(mrq)

0.50%

Book Value Per Share(mrq)

0.36

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.23

Free Cash Flow(ytd)

-6.17M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

OCX

Oncocyte Corporation Common Stock

Oncocyte Corporation Common Stock Profile